STOCK TITAN

Medifast - MED STOCK NEWS

Welcome to our dedicated page for Medifast news (Ticker: MED), a resource for investors and traders seeking the latest updates and insights on Medifast stock.

Medifast Inc (MED) provides investors and stakeholders with centralized access to official company announcements and market-moving developments. This resource aggregates all press releases, financial disclosures, and strategic updates from the clinical nutrition leader known for its OPTAVIA® coaching programs and evidence-based weight management solutions.

Users will find chronological updates covering earnings reports, product innovations, leadership changes, and operational milestones. The curated collection serves as both historical record and strategic tool for tracking MED's position in the $250B+ global wellness industry.

Key content categories include quarterly financial results, clinical study publications, partnership announcements, and regulatory filings. All materials are sourced directly from Medifast's investor relations team to ensure accuracy and timeliness.

Bookmark this page for streamlined monitoring of MED's business trajectory, with updates organized to highlight material developments affecting long-term growth in the health solutions sector.

Rhea-AI Summary

Medifast, Inc. (NYSE: MED) has declared a $1.42 quarterly cash dividend, payable on February 8, 2022, to stockholders of record by December 21, 2021. The company aims to maintain a quarterly dividend program, subject to the Board's discretion. Medifast is known for its health and wellness community, offering OPTAVIA® products and coaching. The company has been recognized in various industry rankings, including FORTUNE's 100 Fastest-Growing Companies list.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.69%
Tags
dividends
-
Rhea-AI Summary

Medifast reported robust Q3 2021 results, showcasing a 52.3% revenue increase to $413.4 million compared to Q3 2020. Active OPTAVIA Coaches grew 44.9% to 61,000, with revenue per Coach rising 7.0% to $6,773. Net income surged 21.9% to $42.0 million, yielding an EPS of $3.56, up 22.3%. Despite these gains, gross profit margin slightly decreased to 74.3% and SG&A expenses climbed 57.9%. The company anticipates full-year revenue between $1.51 billion and $1.53 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.92%
Tags
-
Rhea-AI Summary

Medifast, Inc (NYSE: MED) will announce its third-quarter financial results for the period ending September 30, 2021, on November 4, 2021, after the market closes. The conference call, featuring CEO Dan Chard and CFO Jim Maloney, will begin at 4:30 p.m. ET, accessible via their website or by phone. Medifast is recognized for its OPTAVIA® health and wellness community, which has influenced 2 million lives, offering scientifically developed products and support for healthy habits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
Rhea-AI Summary

Medifast (NYSE: MED) hosted its third annual Healthy Habits For All Week from September 20-26, 2021, aimed at improving health education and access in underserved communities. The event included employee volunteers distributing back-to-school bags and Chromebooks to local students in Baltimore. Medifast collaborated with nonprofits like No Kid Hungry, raising over $900,000 to provide up to 9 million meals for children in need. CEO Dan Chard emphasized the initiative's alignment with the company's mission to promote wellness among future generations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
-
Rhea-AI Summary

Medifast (NYSE: MED) released survey findings indicating that support is essential for individuals pursuing health and wellness goals. Notably, 66% of U.S. adults reported that support has aided their journeys, while 81% believe having experienced support increases the likelihood of success in developing healthy habits. The survey also identified key support types: informational (75%), emotional (70%), and affirmational (70%). The OPTAVIA program emphasizes the importance of Coach support, aligning with these insights to foster client success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
-
Rhea-AI Summary

Medifast, Inc. (NYSE: MED) announced a quarterly cash dividend of $1.42 per share, payable on November 8, 2021, to shareholders of record by September 21, 2021. The company aims to maintain a quarterly dividend program, yet future declarations depend on the Board of Directors' discretion. Medifast has established itself as a leader in the health and wellness sector, supporting clients through its OPTAVIA® platform. Factors influencing future dividend declarations include operational performance and market conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.63%
Tags
dividends
Rhea-AI Summary

Medifast, Inc (NYSE: MED) announced that its Chairman and CEO, Dan Chard, along with CFO Jim Maloney, will present at the Jefferies Virtual Fitness & Wellness Summit on September 15, 2021, at 11:00 a.m. ET. This presentation will be broadcast live via the Investor Relations section of Medifast's website and archived until September 29, 2021. Medifast is recognized for its OPTAVIA® program, which promotes healthy living through scientifically developed products and community support, impacting over 2 million lives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
conferences
-
Rhea-AI Summary

On August 11, 2021, Medifast (NYSE: MED) launched the OPTAVIA app, enhancing its digital services for Clients and Coaches. This app, which has already been downloaded nearly 150,000 times, offers features like Lean & Green recipes, order history, and account management. The initiative is part of Medifast's strategy to improve digital infrastructure, enabling Coaches to better support Clients. The app's development reflects a commitment to continuous improvement based on user feedback, with plans for further enhancements and the upcoming OPTAVIA Connect app aimed at boosting Coach productivity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
none
-
Rhea-AI Summary

Medifast (NYSE: MED) reported strong Q2 results for 2021, with revenue surging 79.2% to $394.2 million, driven by a 62.2% increase in active OPTAVIA Coaches to 59,200. Net income rose 114.1% to $47 million, translating to earnings per share (EPS) of $3.96. The company achieved a gross profit increase of 84.4%, reaching $293.7 million. Despite a 77.0% rise in SG&A expenses, operating income improved significantly. For FY 2021, Medifast anticipates revenue between $1.425 billion and $1.525 billion, with EPS guidance of $12.70 to $14.17.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.38%
Tags
Rhea-AI Summary

Medifast (NYSE: MED) successfully hosted its annual OPTAVIA Convention from July 29 to August 1, 2021, in a hybrid format, attracting over 15,000 registrants. The event featured Coach-led educational sessions, community engagement activities, and celebrations for independent Coaches and their clients. A philanthropic fundraising initiative raised over $100,000 to provide nutritious meals for children in need, contributing to a total of 8 million meals funded to date. CEO Dan Chard emphasized the importance of connection and support amidst the challenges brought by the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.13%
Tags
none
Medifast

NYSE:MED

MED Rankings

MED Stock Data

130.38M
10.51M
2.55%
83.35%
12.75%
Personal Services
Miscellaneous Food Preparations & Kindred Products
Link
United States
OWINGS MILLS